Publications by authors named "Y G Chami"
Background: In Morocco, much progress has been made in breast cancer treatment. However, there is limited information on survival outcomes of breast cancer patients according to their therapeutic management.
Methods: A pattern-of-care study was conducted in Morocco's two main oncology centres: Rabat and Casablanca and has shown that major progress has been made in the quality of care with survival rates comparable to those in developed countries.
Article Synopsis
- This study in Morocco analyzed the cancer patient journey to identify delays in diagnosis and treatment, highlighting how most patients are diagnosed at advanced stages.
- It involved interviewing 812 recently diagnosed cancer patients across major oncology centers to assess timeframes for various stages of their care.
- Key findings indicated that while the patient interval and treatment times met international guidelines, the diagnosis interval was significantly longer than recommended, which emphasizes the need for improved pathways for cancer care in the region.*
It is quite well documented that the COVID-19 pandemic disrupted cancer screening services in all countries, irrespective of their resources and healthcare settings. While quantitative estimates on reduction in volume of screening tests or diagnostic evaluation are readily available from the high-income countries, very little data are available from the low- and middle-income countries (LMICs). From the CanScreen5 global cancer screening data repository we identified six LMICs through purposive sampling based on the availability of cancer screening data at least for the years 2019 and 2020.
View Article and Find Full Text PDFArticle Synopsis
- A study was conducted at two major oncology centers in Morocco to assess delays and adherence to treatment guidelines for cervical cancer from 2008 to 2017, involving 886 patients.
- Findings indicated significant delays in accessing care (5 months) and treatment (2.3 months), with many patients not receiving optimal treatments like brachytherapy.
- The overall 5-year disease-free survival was 57.5%, highlighting the need for reduced delays and increased use of chemoradiation and brachytherapy to enhance survival outcomes.